Overview

Safety and Efficacy of Drug Combinations Against Trichuris Trichiura

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of albendazole (ALB), mebendazole (MBD) and ivermectin (IVM) separately, and ALB and MBD each in combination with IVM in the treatment of Trichuris trichiura in children aged 5-14 years.
Phase:
N/A
Details
Lead Sponsor:
DBL -Institute for Health Research and Development
Treatments:
Albendazole
DMP 777
Ivermectin
Mebendazole
Piperazine
Piperazine citrate